Background-The efficacy of additional complex fractionated atrial electrogram (CFAE) ablation after pulmonary vein antrum isolation (PVAI) in patients with atrial fibrillation (AF) remains controversial. This meta-analysis was performed to assess the additional efficacy of CFAEs ablation after a single procedure without antiarrhythmic drugs. Methods and Results-Trials were identified in MEDLINE, Cochrane Library, Embase, Google Scholar, reviews, and reference lists of relevant papers. Controlled cohort studies comparing the long-term efficacy of combined CFAEs plus PVAI ablation with PVAI alone were included. The primary end point was the maintenance of sinus rhythm without antiarrhythmic drugs. Seven controlled trials (9 comparisons) with a total of 622 participants (332 patients underwent PVAI plus CFAE ablation and 330 patients underwent PVAI alone) were included in the meta-analysis. In an overall pooled estimate, compared with PVI alone, long-term rates of sinus rhythm maintenance (relative risk, 1.17, 95% confidence interval, 1.03 to 1.33, Pϭ0.019) were increased by additional CFAE ablation. Subgroup analysis demonstrated that additional CFAEs ablation increased rates of sinus rhythm maintenance in nonparoxysmal AF (relative risk, 1.35; 95% confidence interval, 1.04 to 1.75; Pϭ0.022), whereas had no effect on patients with paroxysmal AF (relative risk, 1.04; 95% confidence interval, 0.92 to 1.18; Pϭ0.528). Conclusions-Adjuvant CFAE ablation in addition to standard PVAI increases the rate of long-term sinus rhythm maintenance in nonparoxysmal AF patients after a single procedure without antiarrhythmic drugs but does not provide additional benefit to sinus rhythm maintenance in paroxysmal AF patients. (Circ Arrhythm Electrophysiol. 2011;4:143-148.) 
A trial fibrillation (AF) is the most common type of tachyarrhythmia encountered in clinical practice. 1 The pulmonary veins (PVs) and pulmonary vein antrum have been shown to play a major role in the initiation and the maintenance of AF. 2, 3 Pulmonary vein antrum isolation (PVAI) has become the mainstream catheter ablation of AF. However, this strategy has limited success in curing AF, especially in nonparoxysmal AF. 4, 5 Nademanee et al 5a have advocated complex fractionated atrial electrogram (CFAEs) ablation in AF patients as a solitary ablation strategy and obtained encouraging initial results; however, several later studies have found that ablation of CFAEs alone have a relatively low success rate (33%). 6, 7 Recently, CFAE ablation has been used as an additional procedure after PVAI in many AF therapy centers. Several small prospective cohort studies have compared the efficiency of PVAI plus ablation of CFAEs with PVAI alone in patients with paroxysmal or nonparoxysmal AF. However, most of these studies were small, the conclusions were inconsistent, and the efficacy of additional CFAE ablation is therefore debatable. The objective of the present meta-analysis was to assess the effects of additional CFAE ablation after a single PVAI procedure on the maintenance of sinus rhythm. atrial electrograms," or "substrate ablation," without language and time limitation.
Study Selection
Controlled cohort studies designed to assess the efficacy of additional CFAE ablation combined with a PVAI-based procedure were included in this meta-analysis. Criteria for inclusion were as follows:
(1) peer-reviewed, full-length articles, (2) the efficacy of CFAE ablation as additional procedure to PVAI-based procedure was evaluated, and (3) follow-up numeric representation of sinus rhythm maintenance without antiarrhythmic drugs could be calculated. Trials included patients with paroxysmal or nonparoxysmal AF. Publications that could not offer follow-up sinus rhythm maintenance data were excluded.
Data Extraction
All literature searches were independently reviewed by 2 authors (L.W.J. and B.Y.Y.) to identify relevant trials that met the inclusion criteria. Disparities were resolved by discussion. Data on trial size, patient characteristics (age, sex, AF duration, left ventricular size, left ventricular ejection fraction, etc), procedure duration, fluoroscopy exposure time, and patient number of sinus rhythm maintenance without antiarrhythmic drugs were extracted, using a standardized protocol and reporting form. For trials that reported results at multiple time points, the data of the longest follow-up time were included in the analysis.
Data Analysis
The primary outcome of the present meta-analysis was the change in the rate of long-term sinus rhythm maintenance caused by additional CFAE ablation. The relative risk (RR), comparing the rate of the maintenance of sinus rhythm in the CFAE plus PVAI group with that of the PVAI alone group was calculated to express the effects of additional CFAE ablation. Estimates of pooled outcomes with 95% confidence intervals (CIs) were calculated by using random-effect (DerSimonian and Laird) models. 8 Statistical heterogeneity of ablation effects between studies were formally tested with the Cochran test (PϽ0.1). The I 2 statistic was also examined, and we considered I 2 Ͼ50% to indicate significant heterogeneity between the trials. 9 Publication bias was assessed with funnel plots and the Egger regression test. 10 Statistical analyses were performed with Stata software (version 9.0; Stata Corporation, College Station, TX) and REVMAN software (version 5.0; Cochrane Collaboration, Oxford, United Kingdom).
Results

Search Results
A total of 1427 relevant articles were identified in a combined search of MEDLINE, Cochrane Library, Embase, Google Scholar, and by a manual approach (search of studies cited in previous reviews and of reference lists from the identified articles); 1417 articles were excluded because they were not controlled trials or their ablation method were not relevant to the purpose of this meta-analysis (such as trials investigating the efficacy of additional substrate modification added to PAVI by left atrial linear lesions 6 ). Full text assessment of the 10 potentially relevant articles resulted in 7 eligible controlled studies ( Figure 1 ). The reasons for exclusion were as follows: CFAEs ablation was used as a stand-alone strategy for AF ablation 11 ; data of sinus rhythm maintenance after 1 ablation procedure was not offered 12 ; the sites of additional CFAE ablation formed lines along the left atrial septum, roof, posterior mitral annulus, and/or anterior wall, therefore the CFAE ablation was in fact linear ablation procedure. 13 Eventually, 7 trials with a total of 662 subjects were included in the meta-analysis. 14 -20 
Study Characteristics
Characteristics of the trials included in the analysis are shown in Table 1 . The average age of patients included in these trials varied from 49 to 62 years. Four 14, 17, 18, 20 were randomized, controlled trials (RCT) and the other 3 were placebocontrolled trials without randomization. The follow-up duration varied from 12 to 19 months. The detailed procedures of the trials are listed in Table 2 . In brief, antiarrhythmic drugs were discontinued at least 5 half-lives before ablation in all patients except amiodarone, which was discontinued at least 2 months before the procedure in 7 studies. PV isolation was verified in all patients. CFAEs were defined as atrial electrograms with fractionation and composed of 2 defections or more and/or with continuous activity of the baseline or atrial electrograms with a cycle length Ͻ120 ms in 5 studies and an averaged fractionated interval of Ͻ50 ms over 5 seconds in 1 study. The CFAE ablation procedural end point was elimination of the CFAE potentials or prolongation of the fractionated interval (Ն120 ms). The number of patients free from late symptomatic or asymptomatic AF/atrial tachycardia (AT) without antiarrhythmic drug therapy after a single ablation procedure could be obtained in all of the 7 studies.
Efficacy of Additional CFAE Ablation
Seven trials evaluated the effect of additional CFAE ablation on the maintenance of sinus rhythm in AF patients. One work of Verma et al 16 was separated into 2 studies (effects of additional CFAE ablation on patients with paroxysmal and nonparoxysmal AF were reported separately). Another recently published work of Verma et al 14 (the STAR AF study) was also separated into 2 studies for the same reason. Thus, 7 trials with 9 comparisons (662 patients with AF, 332 patients underwent PVAI plus CFAEs ablation, and 330 patients underwent PVAI alone) were included in the final analysis.
In an overall pooled estimate, compared with PVAI alone, long-term rates of sinus rhythm maintenance (relative risk [RR], 1.17; 95% CI, 1.03 to 1.33; Pϭ0.019) were increased by additional CFAE ablation. No significant heterogeneity for this outcome was found (heterogeneity test: I 2 ϭ31.5%, Pϭ0.166) ( Figure 2 ). Subgroup analysis demonstrated that additional CFAE ablation increased rates of sinus rhythm maintenance in nonparoxysmal AF (RR, 1.35; 95% CI, 1.04 to 1.75; Pϭ0.022) but had no effect on patients with paroxysmal AF (RR, 1.04; 95% CI, 0.92 to 1.18; Pϭ0.528) (Figure 3 ).
Both RCTs and nonrandomized trials were included in the present meta-analysis. Subgroup analysis by RCT/non-RCT was performed to investigate whether this feature of study design would influence the effectiveness of additional CFAE ablation. No significant differences in effect size between RCT and non-RCT studies were found (test of heterogeneity between groups: Pϭ0.161).
A statistical analysis of funnel plots suggested no publication bias (Eggers test, Pϭ0.14) (Figure 4 ).
Discussion
The present meta-analysis found that, as compared with PVAI alone, additional CFAEs ablation after PVAI procedure slightly increased the rate of sinus rhythm maintenance in nonparoxysmal AF patients but did not show benefit in paroxysmal AF patients. The present meta-analysis included RCTs and nonrandomized trials; however, we did not find significant differences in effect size between RCTs and non-RCTs.
The baseline characteristics were balanced between PVAI and PVAIϩCFAE groups in all of analyzed trials; therefore, Verma-1A indicates study of paroxysmal atrial fibrillation (AF); Verma-1B, study of nonparoxysmal AF; Verma-3A, study of paroxysmal AF; Verma-3B, study of nonparoxysmal AF; P, pulmonary vein antrum isolation; C, complex fractionated atrial electrogram; LA, left atrium; RCT, randomized controlled trial; and MC, matched controlled study. 
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the outcomes of 2 groups were comparable. Although the definitions of CFAEs, the areas of CFAE ablation, and the end points of CFAEs ablation were not absolutely same, they were similar in most of the selected trials, and all the trials were designed to assess the effect of additional CFAE ablation on sinus rhythm maintenance; thus, it was reasonable to perform a meta-analysis of them. The areas of PV ostia are important for AF initiation and maintenance. It has been well known that most triggers for AF are located in the areas of PV, and the incidence of PV firing increases with progressively wider left atrial-PV connections. 3 Nerve density associated with AF occurrence is significantly higher at the ostia of the 4 PVs than in their distal part of left atrium in humans. 21 CFAEs have been postulated to indicate the areas of slow conduction, collision, anchor points for reentrant circuits, 22 wave break, and fibril-latory conduction at the periphery of a rotor, an anatomic barrier such as the septopulmonary bundle 23 or passive depolarization due to anisotropy, summation of electrograms from overlapping layers of myocardium, 24 or associated with electrophysiological activity. Up to now, PAVI has become cornerstone strategy of AF ablation; however, the efficacy of CFAE ablation remains controversial. 7 It is still inconclusive if termination of AF during ablation is a predictor of long-term sinus maintenance 15, 25 ; however, acute termination of AF might demonstrate successful alteration of the AF substrate. In the included trials of this meta-analysis, the rate of termination of AF during ablation was unaffected by additional CFAE ablation in paroxysmal AT patients but was significantly increased in nonparoxysmal AF patients, which might result in the higher overall longterm sinus maintenance rate in nonparoxysmal AF patients. It was not surprising that additional CFAE ablation provided little benefit to patients with paroxysmal AF, which can be partly explained by the phenomenon that the PV antra are the major source of triggers for paroxysmal AF, 26 and that the density of CFAEs around the PVs was significantly higher than in other regions. In addition, CFAEs appeared critical for the maintenance of the AF in the antral region. Thus, performing extensive ablation at other CFAE sites has not been expected to provide much further benefit in paroxysmal patients. Morady et al 5 suggest that CFAEs present in other areas (coronary sinus, left atrial roof, and mitral annulus) should be considered as "innocent bystanders," at least in the paroxysmal AF patients. Recent studies have indicated that CFAEs are sites of ganglionated plexi that may be implicated in the perpetuation of paroxysmal AF. 8 However, selective ganglionated plexi ablation directed by high-frequency stimulation does not eliminate paroxysmal AF in the majority of patients. 27 Previous studies have shown that CFAE ablation, when used as a stand-alone strategy, results in low sinus rhythm maintenance rate, 11, 14, 20 indicating that CFAE is not the key maintenance mechanism of nonparoxysmal AF. For example, PVAI results in a significant decrease in both PV and non-PV areas of CFAEs, 28 during catheter ablation of CFAEs, persistent AF may convert to ATs, and spectral component analysis has found that ATs observed during ablation of AF is often drivers of AF that become manifest after elimination of higher-frequency sources and fibrillatory conduction. 29 Studies have indicated that left atrial ATs after PVAI can be due to a macroreentrant or focal mechanism, 30 and approximately 90% of ATs after PVAI are reentrant, and nearly all are related to gaps in prior ablation lines. 31 These findings suggest that PVAI should be the main strategy to interfere nonparoxysmal AF. This meta-analysis found that adjuvant CFAEs ablation improved the maintenance rate of sinus rhythm by about 35% in patients with nonparoxysmal AF, which supported the viewpoint that the focal mechanism is also involved in nonparoxysmal AF.
The meta-analysis is limited by the sample sizes and the follow-up period of the included trials. The total number of patients is relatively small for a meta-analysis, and the follow-up period is also relatively short. In addition, because the benefit was extremely small, further studies should be performed to verify whether additional CFAE ablation helps with nonparoxysmal AF. Future research efforts should concentrate on higher-quality and more rigorous randomized trials with longer follow-ups to resolve the uncertainty regarding the clinical effectiveness and safety of additional CFAE ablation in patients with AF.
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